Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Thromboxane | 80 | 2011 | 122 | 5.020 |
Why?
|
Blood Platelets | 76 | 2005 | 284 | 4.510 |
Why?
|
Receptors, Prostaglandin | 53 | 1998 | 74 | 4.170 |
Why?
|
Thromboxane A2 | 68 | 2011 | 88 | 3.270 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 30 | 2003 | 64 | 2.090 |
Why?
|
Shock, Septic | 43 | 2015 | 101 | 1.990 |
Why?
|
Thromboxane B2 | 61 | 2011 | 108 | 1.830 |
Why?
|
Thromboxanes | 39 | 2002 | 53 | 1.830 |
Why?
|
Prostaglandin Endoperoxides, Synthetic | 38 | 1996 | 52 | 1.690 |
Why?
|
Muscle, Smooth, Vascular | 23 | 2001 | 317 | 1.590 |
Why?
|
Platelet Aggregation | 48 | 2005 | 127 | 1.360 |
Why?
|
Prostaglandins H | 25 | 1994 | 32 | 1.360 |
Why?
|
Testosterone | 12 | 2005 | 96 | 1.310 |
Why?
|
MicroRNAs | 10 | 2022 | 447 | 1.270 |
Why?
|
Endotoxins | 28 | 2008 | 76 | 1.250 |
Why?
|
Fatty Acids, Unsaturated | 32 | 2003 | 84 | 1.250 |
Why?
|
Receptors, Thromboxane A2, Prostaglandin H2 | 37 | 2014 | 48 | 1.190 |
Why?
|
Lipopolysaccharides | 31 | 2019 | 455 | 1.080 |
Why?
|
Arachidonic Acids | 40 | 1995 | 97 | 1.040 |
Why?
|
Sepsis | 10 | 2022 | 233 | 1.020 |
Why?
|
Bridged Bicyclo Compounds | 18 | 1997 | 29 | 0.900 |
Why?
|
Animals | 175 | 2022 | 20877 | 0.890 |
Why?
|
Cardiovascular Diseases | 9 | 2018 | 938 | 0.800 |
Why?
|
Thromboxane-A Synthase | 12 | 2011 | 24 | 0.790 |
Why?
|
Rats | 87 | 2003 | 5300 | 0.780 |
Why?
|
Prostaglandin Endoperoxides | 12 | 1990 | 13 | 0.750 |
Why?
|
Aspirin | 13 | 2003 | 295 | 0.740 |
Why?
|
Receptors, Cell Surface | 13 | 2005 | 248 | 0.720 |
Why?
|
Epoprostenol | 22 | 2001 | 71 | 0.720 |
Why?
|
Radioligand Assay | 27 | 2003 | 109 | 0.670 |
Why?
|
Aorta | 14 | 2001 | 316 | 0.650 |
Why?
|
Cooperative Behavior | 2 | 2016 | 235 | 0.600 |
Why?
|
In Vitro Techniques | 45 | 2003 | 765 | 0.600 |
Why?
|
Pericytes | 5 | 2022 | 81 | 0.590 |
Why?
|
Affinity Labels | 8 | 1998 | 66 | 0.590 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2011 | 138 | 0.590 |
Why?
|
Protein Isoforms | 6 | 2011 | 246 | 0.590 |
Why?
|
Macrophages, Peritoneal | 11 | 2012 | 67 | 0.580 |
Why?
|
Prostaglandins | 19 | 1994 | 65 | 0.560 |
Why?
|
Prostaglandins E | 28 | 1986 | 54 | 0.560 |
Why?
|
SRS-A | 12 | 1991 | 20 | 0.540 |
Why?
|
Macrophages | 28 | 2012 | 647 | 0.530 |
Why?
|
Urinary Bladder | 13 | 1985 | 108 | 0.510 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 3 | 2022 | 106 | 0.510 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 24 | 2014 | 41 | 0.500 |
Why?
|
GTP-Binding Proteins | 12 | 2006 | 231 | 0.490 |
Why?
|
Kinetics | 26 | 1998 | 1047 | 0.490 |
Why?
|
Amlodipine | 2 | 2005 | 31 | 0.480 |
Why?
|
Humans | 140 | 2022 | 68525 | 0.480 |
Why?
|
6-Ketoprostaglandin F1 alpha | 27 | 1995 | 42 | 0.480 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 8 | 2003 | 73 | 0.470 |
Why?
|
Social Support | 1 | 2016 | 423 | 0.470 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 7 | 2011 | 47 | 0.450 |
Why?
|
Iodine Radioisotopes | 18 | 2001 | 119 | 0.420 |
Why?
|
Lung | 13 | 2021 | 849 | 0.420 |
Why?
|
Cyclooxygenase Inhibitors | 11 | 2006 | 72 | 0.410 |
Why?
|
Isoenzymes | 6 | 2003 | 308 | 0.410 |
Why?
|
Calcium | 18 | 2003 | 929 | 0.410 |
Why?
|
Vasopressins | 10 | 1985 | 33 | 0.410 |
Why?
|
Signal Transduction | 16 | 2020 | 2688 | 0.400 |
Why?
|
Tumor Necrosis Factor-alpha | 15 | 2012 | 626 | 0.390 |
Why?
|
Cells, Cultured | 30 | 2018 | 2673 | 0.390 |
Why?
|
Platelet Aggregation Inhibitors | 6 | 2003 | 373 | 0.390 |
Why?
|
Receptors, Immunologic | 4 | 1991 | 72 | 0.380 |
Why?
|
Flutamide | 4 | 2005 | 10 | 0.360 |
Why?
|
Arachidonic Acid | 29 | 1998 | 86 | 0.360 |
Why?
|
Cell Line | 12 | 2021 | 1752 | 0.360 |
Why?
|
Male | 94 | 2020 | 37281 | 0.350 |
Why?
|
Cyclooxygenase 1 | 3 | 2006 | 29 | 0.350 |
Why?
|
Inflammation | 10 | 2019 | 1030 | 0.340 |
Why?
|
Fatty Acids, Essential | 11 | 1990 | 16 | 0.340 |
Why?
|
Staphylococcus aureus | 7 | 2007 | 175 | 0.340 |
Why?
|
Endothelial Progenitor Cells | 2 | 2019 | 15 | 0.330 |
Why?
|
Binding, Competitive | 15 | 1998 | 165 | 0.330 |
Why?
|
Cocaine-Related Disorders | 2 | 2005 | 504 | 0.330 |
Why?
|
Leukemia, Erythroblastic, Acute | 5 | 1996 | 15 | 0.330 |
Why?
|
Calcium Channel Blockers | 3 | 2005 | 137 | 0.330 |
Why?
|
Mice | 28 | 2022 | 8472 | 0.330 |
Why?
|
Monocytes | 8 | 2006 | 210 | 0.330 |
Why?
|
Prostaglandin H2 | 14 | 1994 | 16 | 0.320 |
Why?
|
Hydrazines | 10 | 2003 | 23 | 0.320 |
Why?
|
Imidazoles | 16 | 1986 | 175 | 0.320 |
Why?
|
Biomarkers, Tumor | 1 | 2011 | 508 | 0.310 |
Why?
|
Blood Pressure | 15 | 2002 | 1447 | 0.310 |
Why?
|
Diethyl Pyrocarbonate | 3 | 1997 | 4 | 0.310 |
Why?
|
Indomethacin | 23 | 1996 | 107 | 0.300 |
Why?
|
Cyclooxygenase 2 | 4 | 2006 | 160 | 0.300 |
Why?
|
Castration | 2 | 2005 | 13 | 0.300 |
Why?
|
Vasoconstrictor Agents | 6 | 2001 | 107 | 0.290 |
Why?
|
Androgen Antagonists | 2 | 2005 | 44 | 0.290 |
Why?
|
Capillary Permeability | 7 | 2018 | 69 | 0.290 |
Why?
|
Biomedical Research | 2 | 2015 | 310 | 0.290 |
Why?
|
Azides | 4 | 1990 | 56 | 0.290 |
Why?
|
Hemodynamics | 13 | 1991 | 705 | 0.290 |
Why?
|
Estradiol | 4 | 1995 | 176 | 0.280 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2006 | 239 | 0.280 |
Why?
|
Salmonella enteritidis | 16 | 2001 | 24 | 0.280 |
Why?
|
Endothelial Cells | 3 | 2020 | 384 | 0.270 |
Why?
|
Dinoprost | 3 | 2003 | 27 | 0.270 |
Why?
|
Membrane Proteins | 5 | 2006 | 617 | 0.270 |
Why?
|
Gene Expression Regulation | 7 | 2020 | 1293 | 0.260 |
Why?
|
Fatty Acids, Monounsaturated | 4 | 1997 | 29 | 0.260 |
Why?
|
Blood Vessels | 6 | 1989 | 102 | 0.260 |
Why?
|
Arrestins | 3 | 2011 | 92 | 0.250 |
Why?
|
Tetrazoles | 7 | 1991 | 160 | 0.250 |
Why?
|
Tumor Cells, Cultured | 11 | 2007 | 852 | 0.240 |
Why?
|
Cytokines | 8 | 2020 | 866 | 0.240 |
Why?
|
Acetophenones | 6 | 1991 | 12 | 0.240 |
Why?
|
Endotoxemia | 4 | 2012 | 27 | 0.230 |
Why?
|
Ibuprofen | 8 | 1991 | 30 | 0.230 |
Why?
|
Glomerular Mesangium | 3 | 2001 | 53 | 0.230 |
Why?
|
Oleic Acids | 6 | 1989 | 40 | 0.230 |
Why?
|
Cyclic AMP | 11 | 1998 | 223 | 0.230 |
Why?
|
Diabetes Mellitus | 10 | 1985 | 693 | 0.220 |
Why?
|
Chemokine CXCL12 | 2 | 2014 | 51 | 0.220 |
Why?
|
Blotting, Western | 9 | 2019 | 954 | 0.220 |
Why?
|
Diabetic Angiopathies | 8 | 1985 | 203 | 0.220 |
Why?
|
GTP-Binding Protein alpha Subunit, Gi2 | 4 | 2012 | 15 | 0.220 |
Why?
|
Dicarboxylic Acids | 3 | 1991 | 16 | 0.220 |
Why?
|
Headache | 1 | 2002 | 68 | 0.210 |
Why?
|
Kidney | 9 | 2011 | 945 | 0.210 |
Why?
|
Education, Graduate | 2 | 2015 | 30 | 0.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2011 | 756 | 0.210 |
Why?
|
Drug Resistance | 2 | 2002 | 223 | 0.210 |
Why?
|
Rats, Inbred Strains | 16 | 1998 | 532 | 0.200 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 301 | 0.200 |
Why?
|
Prostaglandin Antagonists | 4 | 1986 | 11 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2022 | 2550 | 0.200 |
Why?
|
Coronary Vessels | 4 | 2001 | 313 | 0.200 |
Why?
|
RNA, Long Noncoding | 1 | 2022 | 54 | 0.200 |
Why?
|
Pulmonary Edema | 4 | 1989 | 37 | 0.200 |
Why?
|
Exosomes | 2 | 2019 | 44 | 0.200 |
Why?
|
Cell Membrane | 13 | 1998 | 523 | 0.200 |
Why?
|
Mice, Knockout | 9 | 2022 | 1692 | 0.200 |
Why?
|
Leukotriene B4 | 4 | 1989 | 17 | 0.190 |
Why?
|
Histidine | 2 | 1998 | 17 | 0.190 |
Why?
|
Dihydrotestosterone | 3 | 1997 | 13 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 12 | 2003 | 1745 | 0.190 |
Why?
|
Bacterial Toxins | 3 | 1991 | 50 | 0.190 |
Why?
|
Enterotoxins | 3 | 1991 | 40 | 0.190 |
Why?
|
DNA, Complementary | 5 | 2003 | 251 | 0.190 |
Why?
|
Flavonoids | 1 | 2001 | 109 | 0.190 |
Why?
|
Circulating MicroRNA | 1 | 2020 | 9 | 0.190 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 69 | 0.180 |
Why?
|
Chemokines | 3 | 2020 | 119 | 0.180 |
Why?
|
Bridged-Ring Compounds | 2 | 1990 | 14 | 0.180 |
Why?
|
Macrophage Activation | 4 | 2006 | 75 | 0.180 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 1996 | 9 | 0.180 |
Why?
|
Cardiovascular System | 2 | 2018 | 85 | 0.180 |
Why?
|
Interleukin-6 | 5 | 2012 | 330 | 0.180 |
Why?
|
Sex Characteristics | 2 | 2003 | 295 | 0.170 |
Why?
|
Myocardial Infarction | 2 | 2018 | 807 | 0.170 |
Why?
|
Anti-HIV Agents | 1 | 2001 | 135 | 0.170 |
Why?
|
Anti-Inflammatory Agents | 3 | 2014 | 234 | 0.170 |
Why?
|
Caspase 1 | 1 | 2019 | 22 | 0.170 |
Why?
|
Insulin | 6 | 1993 | 617 | 0.170 |
Why?
|
Bufo marinus | 14 | 1985 | 23 | 0.170 |
Why?
|
Acute Lung Injury | 1 | 2019 | 35 | 0.170 |
Why?
|
Female | 45 | 2020 | 38015 | 0.170 |
Why?
|
Cognitive Dysfunction | 1 | 2022 | 176 | 0.170 |
Why?
|
Oxazoles | 2 | 2003 | 17 | 0.170 |
Why?
|
Dogs | 14 | 1989 | 490 | 0.160 |
Why?
|
Androstadienes | 2 | 2006 | 41 | 0.160 |
Why?
|
Hypertension | 5 | 2018 | 1531 | 0.160 |
Why?
|
Genetic Markers | 1 | 2018 | 144 | 0.160 |
Why?
|
Drug Carriers | 1 | 2019 | 90 | 0.160 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 4 | 2003 | 66 | 0.160 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2019 | 209 | 0.160 |
Why?
|
Prostaglandin D2 | 4 | 2003 | 21 | 0.160 |
Why?
|
Leukotrienes | 4 | 1993 | 13 | 0.160 |
Why?
|
Muscle Contraction | 9 | 2001 | 210 | 0.160 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2019 | 282 | 0.150 |
Why?
|
Enzyme Inhibitors | 2 | 2000 | 659 | 0.150 |
Why?
|
Radioimmunoassay | 9 | 2003 | 164 | 0.150 |
Why?
|
Toll-Like Receptor 4 | 4 | 2012 | 114 | 0.150 |
Why?
|
Nitric Oxide | 7 | 2011 | 382 | 0.150 |
Why?
|
Drug Tolerance | 15 | 2001 | 80 | 0.150 |
Why?
|
Polyethylene Terephthalates | 1 | 1997 | 29 | 0.150 |
Why?
|
Androgens | 1 | 1997 | 40 | 0.150 |
Why?
|
Thiazolidinediones | 3 | 2003 | 76 | 0.150 |
Why?
|
MAP Kinase Signaling System | 5 | 2014 | 247 | 0.150 |
Why?
|
Polytetrafluoroethylene | 1 | 1997 | 55 | 0.150 |
Why?
|
Phosphorylation | 11 | 2014 | 1199 | 0.150 |
Why?
|
Alzheimer Disease | 1 | 2022 | 563 | 0.140 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 177 | 0.140 |
Why?
|
Toll-Like Receptor 2 | 3 | 2012 | 34 | 0.140 |
Why?
|
NF-kappa B | 6 | 2020 | 432 | 0.140 |
Why?
|
Androstenedione | 1 | 1996 | 7 | 0.140 |
Why?
|
COS Cells | 4 | 2003 | 155 | 0.140 |
Why?
|
Leukocyte Count | 3 | 1991 | 94 | 0.140 |
Why?
|
Research Personnel | 1 | 2016 | 83 | 0.140 |
Why?
|
Guanylate Cyclase | 1 | 1996 | 25 | 0.140 |
Why?
|
Eicosanoids | 2 | 1993 | 16 | 0.140 |
Why?
|
Guinea Pigs | 8 | 1997 | 124 | 0.140 |
Why?
|
Spleen | 5 | 2011 | 301 | 0.140 |
Why?
|
Dinoprostone | 5 | 1998 | 110 | 0.140 |
Why?
|
Binding Sites | 6 | 2000 | 631 | 0.140 |
Why?
|
Polymerase Chain Reaction | 4 | 2005 | 492 | 0.140 |
Why?
|
Anabolic Agents | 1 | 1995 | 6 | 0.130 |
Why?
|
Blood Vessel Prosthesis | 1 | 1997 | 182 | 0.130 |
Why?
|
Saphenous Vein | 5 | 1990 | 61 | 0.130 |
Why?
|
Nanoparticles | 1 | 2019 | 254 | 0.130 |
Why?
|
Endothelium, Vascular | 4 | 2019 | 371 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 6 | 2008 | 150 | 0.130 |
Why?
|
Cecum | 4 | 2019 | 39 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 6 | 2008 | 147 | 0.130 |
Why?
|
Biology | 1 | 2015 | 14 | 0.130 |
Why?
|
I-kappa B Proteins | 4 | 2003 | 47 | 0.130 |
Why?
|
Peptides | 4 | 2011 | 455 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 1995 | 52 | 0.130 |
Why?
|
Arteriosclerosis | 4 | 1983 | 137 | 0.130 |
Why?
|
Urologic Neoplasms | 1 | 2014 | 14 | 0.130 |
Why?
|
Platelet Count | 7 | 1993 | 100 | 0.130 |
Why?
|
Case-Control Studies | 2 | 2011 | 1548 | 0.130 |
Why?
|
Faculty | 1 | 2015 | 56 | 0.120 |
Why?
|
Body Water | 3 | 1984 | 35 | 0.120 |
Why?
|
Cricetinae | 5 | 2001 | 262 | 0.120 |
Why?
|
Gram-Positive Bacteria | 2 | 2005 | 23 | 0.120 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2014 | 21 | 0.120 |
Why?
|
Structure-Activity Relationship | 7 | 1995 | 420 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2019 | 222 | 0.120 |
Why?
|
Peroxiredoxin VI | 1 | 2014 | 18 | 0.120 |
Why?
|
Adult | 20 | 2015 | 21375 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 94 | 0.120 |
Why?
|
Transcription Factors | 4 | 2003 | 753 | 0.120 |
Why?
|
Solubility | 6 | 1996 | 134 | 0.120 |
Why?
|
Middle Aged | 14 | 2020 | 21119 | 0.120 |
Why?
|
Schools, Medical | 1 | 2015 | 157 | 0.120 |
Why?
|
Heart Failure | 2 | 2018 | 1179 | 0.120 |
Why?
|
Cycloheximide | 4 | 2001 | 50 | 0.120 |
Why?
|
Arginine Vasopressin | 2 | 1983 | 16 | 0.120 |
Why?
|
Iloprost | 2 | 1992 | 4 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 194 | 0.110 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 1993 | 21 | 0.110 |
Why?
|
Cloning, Molecular | 3 | 1999 | 357 | 0.110 |
Why?
|
Xenopus Proteins | 1 | 1993 | 31 | 0.110 |
Why?
|
Multiple Organ Failure | 2 | 2012 | 36 | 0.110 |
Why?
|
Transfection | 5 | 2007 | 782 | 0.110 |
Why?
|
8,11,14-Eicosatrienoic Acid | 2 | 2003 | 4 | 0.110 |
Why?
|
Prostanoic Acids | 6 | 1983 | 9 | 0.110 |
Why?
|
Pilot Projects | 1 | 2016 | 1341 | 0.110 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 1993 | 195 | 0.110 |
Why?
|
Arthritis, Rheumatoid | 2 | 2011 | 155 | 0.110 |
Why?
|
Lipoxygenase Inhibitors | 2 | 1989 | 9 | 0.110 |
Why?
|
src-Family Kinases | 2 | 2003 | 91 | 0.110 |
Why?
|
Pyrazoles | 3 | 2011 | 190 | 0.110 |
Why?
|
Dactinomycin | 3 | 2000 | 31 | 0.100 |
Why?
|
Protein Kinase C | 2 | 2001 | 270 | 0.100 |
Why?
|
Receptors, CXCR4 | 1 | 2012 | 48 | 0.100 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2012 | 34 | 0.100 |
Why?
|
Propranolol | 2 | 1990 | 102 | 0.100 |
Why?
|
Swine | 5 | 1997 | 672 | 0.100 |
Why?
|
ortho-Aminobenzoates | 2 | 1988 | 3 | 0.100 |
Why?
|
Fibrin Fibrinogen Degradation Products | 11 | 1983 | 50 | 0.100 |
Why?
|
Blood Coagulation | 4 | 1991 | 123 | 0.100 |
Why?
|
Arthritis, Experimental | 1 | 2011 | 38 | 0.100 |
Why?
|
Dihydropyridines | 1 | 1991 | 13 | 0.100 |
Why?
|
Linseed Oil | 1 | 1991 | 2 | 0.100 |
Why?
|
Dietary Fats, Unsaturated | 1 | 1991 | 8 | 0.100 |
Why?
|
Calcium Channel Agonists | 1 | 1991 | 18 | 0.100 |
Why?
|
Furosemide | 2 | 1982 | 45 | 0.100 |
Why?
|
Pertussis Toxin | 6 | 2011 | 72 | 0.100 |
Why?
|
Pre-Eclampsia | 1 | 1993 | 202 | 0.100 |
Why?
|
Renin | 4 | 1983 | 96 | 0.100 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2011 | 46 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 5 | 1995 | 618 | 0.100 |
Why?
|
CHO Cells | 3 | 2001 | 161 | 0.100 |
Why?
|
Brain Injuries | 1 | 2014 | 268 | 0.100 |
Why?
|
Prognosis | 4 | 2020 | 2093 | 0.100 |
Why?
|
Vasoconstriction | 5 | 2001 | 81 | 0.100 |
Why?
|
Molecular Sequence Data | 4 | 1998 | 1446 | 0.100 |
Why?
|
Recovery of Function | 1 | 2014 | 506 | 0.090 |
Why?
|
Drug Interactions | 5 | 2001 | 289 | 0.090 |
Why?
|
Leukopenia | 4 | 1991 | 23 | 0.090 |
Why?
|
Cell Movement | 4 | 2020 | 630 | 0.090 |
Why?
|
Kallikreins | 4 | 1985 | 323 | 0.090 |
Why?
|
Theophylline | 3 | 1984 | 22 | 0.090 |
Why?
|
Ligation | 3 | 2019 | 83 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 507 | 0.090 |
Why?
|
Biomarkers | 4 | 2018 | 1593 | 0.090 |
Why?
|
Sequence Analysis, DNA | 2 | 2003 | 208 | 0.090 |
Why?
|
Peroxidase | 3 | 2019 | 40 | 0.090 |
Why?
|
Sulfonamides | 1 | 2011 | 141 | 0.090 |
Why?
|
Hematocrit | 5 | 1991 | 70 | 0.090 |
Why?
|
Calcimycin | 7 | 1993 | 32 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2014 | 718 | 0.090 |
Why?
|
Extracellular Space | 2 | 1987 | 121 | 0.090 |
Why?
|
Azoles | 2 | 1987 | 7 | 0.090 |
Why?
|
Water | 2 | 1980 | 228 | 0.090 |
Why?
|
Rabbits | 11 | 1994 | 509 | 0.090 |
Why?
|
Lung Injury | 1 | 1989 | 38 | 0.090 |
Why?
|
Carbazoles | 3 | 1996 | 46 | 0.090 |
Why?
|
Problem Solving | 1 | 2009 | 36 | 0.090 |
Why?
|
Second Messenger Systems | 3 | 1995 | 53 | 0.090 |
Why?
|
Mice, Transgenic | 3 | 2022 | 1032 | 0.090 |
Why?
|
Lupus Nephritis | 1 | 2011 | 193 | 0.090 |
Why?
|
Arachidonate Lipoxygenases | 1 | 1988 | 3 | 0.090 |
Why?
|
Sodium | 4 | 1987 | 161 | 0.080 |
Why?
|
Naphthoquinones | 1 | 1988 | 14 | 0.080 |
Why?
|
Fatty Acids | 4 | 1991 | 222 | 0.080 |
Why?
|
Purines | 3 | 2003 | 39 | 0.080 |
Why?
|
Mentors | 1 | 2009 | 81 | 0.080 |
Why?
|
Attitude | 1 | 2009 | 121 | 0.080 |
Why?
|
Lung Diseases | 2 | 1987 | 175 | 0.080 |
Why?
|
Epithelium | 7 | 1985 | 172 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 951 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 1990 | 211 | 0.080 |
Why?
|
Thiazoles | 3 | 2003 | 95 | 0.080 |
Why?
|
Oxidoreductases | 3 | 1983 | 117 | 0.080 |
Why?
|
Thrombocytopenia | 6 | 1991 | 122 | 0.080 |
Why?
|
United States | 2 | 2011 | 7335 | 0.080 |
Why?
|
Tissue Extracts | 1 | 1987 | 10 | 0.080 |
Why?
|
Cell Extracts | 1 | 1987 | 21 | 0.080 |
Why?
|
Calcium Radioisotopes | 1 | 1987 | 4 | 0.080 |
Why?
|
Peritoneal Cavity | 3 | 2010 | 25 | 0.080 |
Why?
|
Intracellular Membranes | 2 | 2001 | 86 | 0.080 |
Why?
|
Interleukin-10 | 3 | 2014 | 144 | 0.080 |
Why?
|
Streptococcus agalactiae | 1 | 2007 | 26 | 0.080 |
Why?
|
Liver | 5 | 2010 | 1118 | 0.080 |
Why?
|
Bacterial Infections | 1 | 1989 | 163 | 0.080 |
Why?
|
Immunoblotting | 3 | 1997 | 254 | 0.070 |
Why?
|
Lysophospholipids | 1 | 2008 | 209 | 0.070 |
Why?
|
Substance-Related Disorders | 2 | 1994 | 1241 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 6 | 2004 | 250 | 0.070 |
Why?
|
Receptors, Leukotriene | 3 | 1991 | 8 | 0.070 |
Why?
|
Thoracic Arteries | 1 | 1986 | 10 | 0.070 |
Why?
|
Transcription, Genetic | 3 | 2014 | 562 | 0.070 |
Why?
|
Mammary Arteries | 1 | 1986 | 18 | 0.070 |
Why?
|
beta-Glucans | 1 | 2006 | 18 | 0.070 |
Why?
|
Norepinephrine | 5 | 1996 | 276 | 0.070 |
Why?
|
Time Factors | 11 | 1996 | 4655 | 0.070 |
Why?
|
Double-Blind Method | 3 | 2002 | 1737 | 0.070 |
Why?
|
Prostaglandins F | 7 | 1983 | 13 | 0.070 |
Why?
|
Phenoxybenzamine | 1 | 1986 | 7 | 0.070 |
Why?
|
Adenosine Diphosphate | 8 | 1985 | 66 | 0.070 |
Why?
|
Vasodilation | 3 | 2001 | 85 | 0.070 |
Why?
|
Colchicine | 2 | 1985 | 48 | 0.070 |
Why?
|
Haplotypes | 1 | 2006 | 174 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 1993 | 1026 | 0.070 |
Why?
|
Pharmacogenetics | 1 | 2006 | 47 | 0.070 |
Why?
|
beta-Arrestin 2 | 3 | 2011 | 29 | 0.070 |
Why?
|
Amino Acid Sequence | 3 | 1998 | 1082 | 0.070 |
Why?
|
Sulindac | 1 | 1985 | 4 | 0.070 |
Why?
|
beta-Arrestins | 3 | 2011 | 80 | 0.070 |
Why?
|
Interferon-gamma | 2 | 2004 | 241 | 0.070 |
Why?
|
Natriuresis | 2 | 1982 | 13 | 0.070 |
Why?
|
Indenes | 1 | 1985 | 6 | 0.070 |
Why?
|
Water-Electrolyte Balance | 3 | 1985 | 43 | 0.070 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 1985 | 13 | 0.070 |
Why?
|
Phenethylamines | 1 | 1985 | 20 | 0.070 |
Why?
|
Stimulation, Chemical | 5 | 2003 | 57 | 0.070 |
Why?
|
Veins | 1 | 1985 | 68 | 0.060 |
Why?
|
Intracellular Fluid | 1 | 1984 | 24 | 0.060 |
Why?
|
Membrane Glycoproteins | 2 | 2005 | 370 | 0.060 |
Why?
|
Photolysis | 3 | 1990 | 16 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 4 | 2001 | 2083 | 0.060 |
Why?
|
Body Fluids | 1 | 1984 | 41 | 0.060 |
Why?
|
Dopamine | 5 | 1978 | 474 | 0.060 |
Why?
|
Substance Abuse Detection | 1 | 2005 | 66 | 0.060 |
Why?
|
Kidney Glomerulus | 3 | 1993 | 155 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2005 | 1663 | 0.060 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 61 | 0.060 |
Why?
|
Patient Dropouts | 1 | 2005 | 98 | 0.060 |
Why?
|
Oleic Acid | 4 | 1988 | 40 | 0.060 |
Why?
|
Protein Synthesis Inhibitors | 2 | 2001 | 32 | 0.060 |
Why?
|
Thiazines | 1 | 1983 | 4 | 0.060 |
Why?
|
Enzyme Activation | 5 | 2003 | 791 | 0.060 |
Why?
|
Fluorocarbons | 1 | 1985 | 82 | 0.060 |
Why?
|
Tetradecanoylphorbol Acetate | 4 | 2001 | 138 | 0.060 |
Why?
|
Carboxylic Acids | 1 | 1983 | 24 | 0.060 |
Why?
|
Verapamil | 1 | 1983 | 30 | 0.060 |
Why?
|
Chromans | 1 | 2003 | 12 | 0.060 |
Why?
|
Reference Values | 2 | 2003 | 579 | 0.060 |
Why?
|
Streptococcus | 1 | 2003 | 15 | 0.060 |
Why?
|
Ion Channels | 1 | 1983 | 72 | 0.060 |
Why?
|
Nitric Oxide Synthase | 2 | 2001 | 163 | 0.060 |
Why?
|
Blood Circulation | 2 | 1987 | 18 | 0.060 |
Why?
|
Gram-Negative Bacteria | 1 | 2003 | 55 | 0.060 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2003 | 8 | 0.060 |
Why?
|
Potassium Chloride | 2 | 1996 | 45 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2006 | 627 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2016 | 7028 | 0.060 |
Why?
|
Deamino Arginine Vasopressin | 1 | 1982 | 15 | 0.060 |
Why?
|
Stereoisomerism | 4 | 1991 | 169 | 0.060 |
Why?
|
Threonine | 1 | 2003 | 47 | 0.060 |
Why?
|
Alanine | 1 | 2003 | 38 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 272 | 0.060 |
Why?
|
Inflammation Mediators | 2 | 2020 | 244 | 0.050 |
Why?
|
Isoquinolines | 3 | 1991 | 37 | 0.050 |
Why?
|
Cysteine | 1 | 2003 | 112 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2005 | 339 | 0.050 |
Why?
|
Poisson Distribution | 1 | 2002 | 84 | 0.050 |
Why?
|
Pain | 1 | 2006 | 472 | 0.050 |
Why?
|
Glycine | 1 | 2003 | 89 | 0.050 |
Why?
|
Hemoglobin Subunits | 1 | 2022 | 4 | 0.050 |
Why?
|
Patient Compliance | 1 | 2005 | 402 | 0.050 |
Why?
|
Outpatients | 1 | 2002 | 127 | 0.050 |
Why?
|
Neoplasm Invasiveness | 3 | 2008 | 369 | 0.050 |
Why?
|
Perfusion | 2 | 1994 | 131 | 0.050 |
Why?
|
Interleukin-1 | 1 | 2001 | 86 | 0.050 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 1996 | 35 | 0.050 |
Why?
|
Angiotensin II | 3 | 1996 | 220 | 0.050 |
Why?
|
Lipopolysaccharide Receptors | 1 | 2001 | 23 | 0.050 |
Why?
|
Myocardium | 2 | 1983 | 1204 | 0.050 |
Why?
|
Papaverine | 3 | 1989 | 10 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2002 | 546 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2014 | 1849 | 0.050 |
Why?
|
Lipoproteins, HDL | 2 | 2016 | 113 | 0.050 |
Why?
|
Blood Glucose | 7 | 1985 | 631 | 0.050 |
Why?
|
Polymyxin B | 2 | 1993 | 5 | 0.050 |
Why?
|
Base Sequence | 2 | 2008 | 1015 | 0.050 |
Why?
|
Adrenergic alpha-Agonists | 2 | 1991 | 57 | 0.050 |
Why?
|
Survival Rate | 2 | 2019 | 1055 | 0.050 |
Why?
|
Cats | 5 | 1986 | 292 | 0.050 |
Why?
|
Motivation | 1 | 2005 | 561 | 0.050 |
Why?
|
Okadaic Acid | 1 | 2000 | 22 | 0.050 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 12 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2001 | 376 | 0.050 |
Why?
|
Ganglia, Autonomic | 2 | 1978 | 10 | 0.050 |
Why?
|
Analysis of Variance | 4 | 2003 | 1039 | 0.050 |
Why?
|
Progesterone | 1 | 2001 | 115 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2019 | 1851 | 0.050 |
Why?
|
Mice, Inbred MRL lpr | 3 | 2011 | 118 | 0.050 |
Why?
|
Comorbidity | 1 | 2005 | 1425 | 0.050 |
Why?
|
Administration, Oral | 2 | 2001 | 411 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2021 | 102 | 0.050 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 190 | 0.050 |
Why?
|
von Willebrand Factor | 5 | 1983 | 47 | 0.050 |
Why?
|
Erythrocytes | 2 | 1990 | 137 | 0.050 |
Why?
|
Cholesterol | 2 | 2016 | 331 | 0.050 |
Why?
|
Microvessels | 1 | 2020 | 43 | 0.050 |
Why?
|
Models, Animal | 1 | 2001 | 252 | 0.050 |
Why?
|
Gentamicins | 3 | 1985 | 68 | 0.040 |
Why?
|
Cocaine | 1 | 2005 | 555 | 0.040 |
Why?
|
Receptors, Drug | 1 | 1979 | 31 | 0.040 |
Why?
|
Virulence Factors, Bordetella | 3 | 2001 | 60 | 0.040 |
Why?
|
Membrane Potentials | 1 | 1980 | 200 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 1070 | 0.040 |
Why?
|
Ligands | 2 | 1991 | 317 | 0.040 |
Why?
|
Trans-Activators | 1 | 2021 | 237 | 0.040 |
Why?
|
RNA Interference | 1 | 2020 | 266 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2011 | 532 | 0.040 |
Why?
|
Escherichia coli K12 | 1 | 2019 | 9 | 0.040 |
Why?
|
Risk Factors | 2 | 2016 | 5719 | 0.040 |
Why?
|
Molecular Structure | 2 | 1991 | 397 | 0.040 |
Why?
|
Leukotriene E4 | 3 | 1988 | 6 | 0.040 |
Why?
|
HMGB1 Protein | 1 | 2019 | 23 | 0.040 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1979 | 32 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2019 | 16 | 0.040 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2019 | 21 | 0.040 |
Why?
|
Serum Albumin | 3 | 1990 | 104 | 0.040 |
Why?
|
Punctures | 1 | 2019 | 35 | 0.040 |
Why?
|
Neutrophils | 1 | 2020 | 204 | 0.040 |
Why?
|
Vitamin D-Binding Protein | 2 | 1989 | 58 | 0.040 |
Why?
|
Pyroptosis | 1 | 2018 | 8 | 0.040 |
Why?
|
Lipoproteins, LDL | 2 | 2016 | 343 | 0.040 |
Why?
|
Cytoplasm | 3 | 2014 | 155 | 0.040 |
Why?
|
Thrombin | 2 | 1995 | 117 | 0.040 |
Why?
|
Trachea | 1 | 2019 | 48 | 0.040 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 1998 | 13 | 0.040 |
Why?
|
Fibroblasts | 5 | 2012 | 902 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2001 | 411 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2005 | 778 | 0.040 |
Why?
|
Acetylglucosamine | 1 | 2019 | 46 | 0.040 |
Why?
|
Cyclic GMP-Dependent Protein Kinases | 1 | 1998 | 10 | 0.040 |
Why?
|
Neutropenia | 2 | 1991 | 72 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2005 | 2264 | 0.040 |
Why?
|
Conserved Sequence | 1 | 1998 | 67 | 0.040 |
Why?
|
Cholic Acids | 2 | 1990 | 8 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 196 | 0.040 |
Why?
|
Epinephrine | 4 | 1985 | 103 | 0.040 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 2 | 1990 | 9 | 0.040 |
Why?
|
Aged | 4 | 2014 | 14842 | 0.040 |
Why?
|
Sequence Alignment | 1 | 1998 | 165 | 0.040 |
Why?
|
Isomerism | 2 | 2003 | 63 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 230 | 0.040 |
Why?
|
Actins | 2 | 1989 | 249 | 0.040 |
Why?
|
Bartter Syndrome | 1 | 1977 | 2 | 0.040 |
Why?
|
Hyperaldosteronism | 1 | 1977 | 5 | 0.040 |
Why?
|
Protein Binding | 3 | 2003 | 1027 | 0.040 |
Why?
|
Cognition | 1 | 2022 | 512 | 0.040 |
Why?
|
Organ Specificity | 1 | 2018 | 167 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 219 | 0.040 |
Why?
|
Cell Division | 4 | 2008 | 541 | 0.040 |
Why?
|
GTP Phosphohydrolases | 4 | 2001 | 46 | 0.040 |
Why?
|
Technetium | 2 | 1990 | 38 | 0.040 |
Why?
|
Splanchnic Circulation | 2 | 1990 | 11 | 0.040 |
Why?
|
Acid Phosphatase | 3 | 1983 | 36 | 0.040 |
Why?
|
Species Specificity | 3 | 1989 | 302 | 0.040 |
Why?
|
Survival Analysis | 2 | 2010 | 714 | 0.040 |
Why?
|
Seminal Vesicles | 1 | 1997 | 7 | 0.040 |
Why?
|
Carotid Arteries | 2 | 1997 | 110 | 0.040 |
Why?
|
RNA | 1 | 1998 | 171 | 0.040 |
Why?
|
Wasp Venoms | 2 | 2011 | 8 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 1997 | 33 | 0.040 |
Why?
|
Methylprednisolone | 3 | 1987 | 99 | 0.040 |
Why?
|
Molecular Weight | 2 | 1989 | 358 | 0.040 |
Why?
|
Tunica Intima | 1 | 1997 | 59 | 0.040 |
Why?
|
Radionuclide Imaging | 2 | 1989 | 166 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 1997 | 73 | 0.040 |
Why?
|
Homeostasis | 2 | 2016 | 291 | 0.040 |
Why?
|
Peritoneum | 2 | 1994 | 27 | 0.040 |
Why?
|
Lipid A | 2 | 1993 | 9 | 0.040 |
Why?
|
Kallidin | 3 | 1985 | 9 | 0.040 |
Why?
|
Brain | 2 | 2022 | 2175 | 0.040 |
Why?
|
Biological Transport | 4 | 1985 | 210 | 0.040 |
Why?
|
Chlorides | 3 | 1985 | 68 | 0.040 |
Why?
|
Hyperlipidemias | 1 | 2016 | 90 | 0.040 |
Why?
|
Chromatography, Affinity | 2 | 1994 | 73 | 0.040 |
Why?
|
Endothelium | 3 | 1986 | 98 | 0.040 |
Why?
|
Ethanol | 1 | 2003 | 892 | 0.040 |
Why?
|
Models, Biological | 1 | 2020 | 981 | 0.030 |
Why?
|
Up-Regulation | 1 | 2018 | 682 | 0.030 |
Why?
|
Leukemia, Myeloid | 1 | 1996 | 39 | 0.030 |
Why?
|
Cell Communication | 1 | 2016 | 116 | 0.030 |
Why?
|
Meclofenamic Acid | 3 | 1985 | 3 | 0.030 |
Why?
|
Nitroprusside | 1 | 1996 | 42 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1982 | 756 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2011 | 146 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1998 | 306 | 0.030 |
Why?
|
Chromatography, Gel | 2 | 1985 | 79 | 0.030 |
Why?
|
Atrial Natriuretic Factor | 1 | 1996 | 54 | 0.030 |
Why?
|
Pregnancy | 3 | 1993 | 2331 | 0.030 |
Why?
|
Plasma | 1 | 2015 | 58 | 0.030 |
Why?
|
Spinal Cord | 2 | 1988 | 244 | 0.030 |
Why?
|
Cyclic GMP | 1 | 1996 | 99 | 0.030 |
Why?
|
Spinal Cord Injuries | 3 | 1988 | 551 | 0.030 |
Why?
|
Permeability | 2 | 1989 | 131 | 0.030 |
Why?
|
Hydroxylamine | 1 | 1995 | 9 | 0.030 |
Why?
|
Tobacco | 1 | 2016 | 161 | 0.030 |
Why?
|
Hydroxylamines | 1 | 1995 | 20 | 0.030 |
Why?
|
Methacrylates | 2 | 1986 | 31 | 0.030 |
Why?
|
Colon | 3 | 1984 | 168 | 0.030 |
Why?
|
Megakaryocytes | 1 | 1995 | 18 | 0.030 |
Why?
|
Training Support | 1 | 2015 | 17 | 0.030 |
Why?
|
Science | 1 | 2015 | 15 | 0.030 |
Why?
|
Chromones | 2 | 2006 | 33 | 0.030 |
Why?
|
Pyridines | 2 | 2002 | 261 | 0.030 |
Why?
|
Receptors, Angiotensin | 1 | 1995 | 59 | 0.030 |
Why?
|
Salaries and Fringe Benefits | 1 | 2015 | 29 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 3 | 2001 | 284 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1995 | 45 | 0.030 |
Why?
|
Methyldopa | 1 | 1974 | 4 | 0.030 |
Why?
|
Forkhead Box Protein O3 | 1 | 2014 | 10 | 0.030 |
Why?
|
Receptors, Epoprostenol | 2 | 1998 | 3 | 0.030 |
Why?
|
Butadienes | 1 | 2014 | 26 | 0.030 |
Why?
|
Morpholines | 2 | 2006 | 79 | 0.030 |
Why?
|
Orchiectomy | 1 | 1994 | 25 | 0.030 |
Why?
|
Cell Adhesion | 1 | 1996 | 324 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 2790 | 0.030 |
Why?
|
Oxidation-Reduction | 2 | 2014 | 567 | 0.030 |
Why?
|
Glucans | 3 | 1990 | 12 | 0.030 |
Why?
|
Toll-Like Receptors | 2 | 2005 | 56 | 0.030 |
Why?
|
Zymosan | 2 | 2012 | 12 | 0.030 |
Why?
|
Nitriles | 1 | 2014 | 68 | 0.030 |
Why?
|
Arginine | 1 | 1995 | 102 | 0.030 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 1991 | 11 | 0.030 |
Why?
|
Kinins | 2 | 1985 | 109 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2014 | 47 | 0.030 |
Why?
|
Phosphorus Radioisotopes | 1 | 1994 | 29 | 0.030 |
Why?
|
Osmolar Concentration | 2 | 1984 | 134 | 0.030 |
Why?
|
Azasteroids | 1 | 1993 | 4 | 0.030 |
Why?
|
Ureteral Obstruction | 1 | 1994 | 25 | 0.030 |
Why?
|
Phosphates | 1 | 1994 | 72 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2015 | 110 | 0.030 |
Why?
|
Cohort Studies | 1 | 2020 | 2356 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 149 | 0.030 |
Why?
|
Myositis Ossificans | 3 | 1978 | 6 | 0.030 |
Why?
|
Lysosomes | 4 | 1983 | 136 | 0.030 |
Why?
|
Fibrinolysis | 2 | 1983 | 55 | 0.030 |
Why?
|
Universities | 1 | 2015 | 191 | 0.030 |
Why?
|
Cell Culture Techniques | 2 | 2006 | 189 | 0.030 |
Why?
|
Data Collection | 1 | 2015 | 420 | 0.030 |
Why?
|
Horses | 1 | 1993 | 20 | 0.030 |
Why?
|
Alprostadil | 2 | 1983 | 20 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1993 | 62 | 0.030 |
Why?
|
Lipopeptides | 1 | 2012 | 7 | 0.030 |
Why?
|
Xanthine Oxidase | 2 | 1989 | 15 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2015 | 281 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2004 | 82 | 0.030 |
Why?
|
Poly I-C | 1 | 2012 | 20 | 0.030 |
Why?
|
Cell Separation | 1 | 1993 | 132 | 0.030 |
Why?
|
Students | 1 | 2015 | 233 | 0.030 |
Why?
|
Vascular Resistance | 3 | 1991 | 179 | 0.030 |
Why?
|
Stem Cells | 1 | 2014 | 248 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2004 | 140 | 0.030 |
Why?
|
Piperazines | 2 | 1991 | 206 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2004 | 134 | 0.030 |
Why?
|
Glucuronidase | 2 | 1983 | 11 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2007 | 1173 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2007 | 1174 | 0.030 |
Why?
|
Cell Survival | 2 | 1992 | 901 | 0.030 |
Why?
|
Lymphocytes | 2 | 2005 | 228 | 0.030 |
Why?
|
Staurosporine | 1 | 1991 | 19 | 0.030 |
Why?
|
Receptors, Leukotriene B4 | 1 | 1991 | 2 | 0.030 |
Why?
|
Bromosuccinimide | 1 | 1991 | 1 | 0.030 |
Why?
|
Oxygen | 3 | 1988 | 386 | 0.030 |
Why?
|
beta-Arrestin 1 | 1 | 2011 | 22 | 0.030 |
Why?
|
Coronary Circulation | 2 | 1983 | 136 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 1994 | 323 | 0.030 |
Why?
|
Benzophenones | 1 | 1991 | 12 | 0.030 |
Why?
|
NF-KappaB Inhibitor alpha | 2 | 2001 | 28 | 0.030 |
Why?
|
Lymphopenia | 1 | 1991 | 12 | 0.030 |
Why?
|
Platelet Activation | 1 | 1991 | 24 | 0.030 |
Why?
|
Camptothecin | 1 | 1991 | 39 | 0.030 |
Why?
|
Peritonitis | 4 | 1985 | 46 | 0.030 |
Why?
|
Blood Volume | 1 | 1991 | 47 | 0.030 |
Why?
|
Platelet Adhesiveness | 3 | 1980 | 20 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2011 | 120 | 0.030 |
Why?
|
Alkaloids | 1 | 1991 | 40 | 0.030 |
Why?
|
Indicators and Reagents | 1 | 1991 | 63 | 0.020 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1991 | 10 | 0.020 |
Why?
|
Muridae | 2 | 1981 | 9 | 0.020 |
Why?
|
Fura-2 | 1 | 1991 | 21 | 0.020 |
Why?
|
Mesentery | 1 | 1991 | 17 | 0.020 |
Why?
|
Pulmonary Wedge Pressure | 2 | 1989 | 102 | 0.020 |
Why?
|
Manganese | 1 | 1991 | 26 | 0.020 |
Why?
|
Cell Membrane Permeability | 3 | 1990 | 59 | 0.020 |
Why?
|
Bacterial Load | 1 | 2011 | 24 | 0.020 |
Why?
|
Sex Factors | 1 | 1995 | 1265 | 0.020 |
Why?
|
Nitrites | 1 | 2011 | 53 | 0.020 |
Why?
|
Phenylephrine | 1 | 1991 | 61 | 0.020 |
Why?
|
Nitrates | 1 | 2011 | 61 | 0.020 |
Why?
|
Hypotension | 1 | 1991 | 74 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2011 | 41 | 0.020 |
Why?
|
Kidney Diseases | 1 | 1994 | 307 | 0.020 |
Why?
|
Indium Radioisotopes | 1 | 1990 | 19 | 0.020 |
Why?
|
Isoproterenol | 2 | 1998 | 163 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1991 | 181 | 0.020 |
Why?
|
Thionucleotides | 1 | 1990 | 21 | 0.020 |
Why?
|
Cholera Toxin | 1 | 1990 | 30 | 0.020 |
Why?
|
Guanosine Triphosphate | 1 | 1990 | 65 | 0.020 |
Why?
|
Cell Count | 1 | 1991 | 248 | 0.020 |
Why?
|
Diuresis | 2 | 1980 | 20 | 0.020 |
Why?
|
Blood | 1 | 2010 | 40 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 696 | 0.020 |
Why?
|
Serotonin | 2 | 2001 | 144 | 0.020 |
Why?
|
Isoflurane | 1 | 1990 | 16 | 0.020 |
Why?
|
Collagen | 4 | 2003 | 636 | 0.020 |
Why?
|
Cardiac Output | 3 | 1991 | 133 | 0.020 |
Why?
|
Dexamethasone | 1 | 1990 | 150 | 0.020 |
Why?
|
Detergents | 1 | 1990 | 34 | 0.020 |
Why?
|
Gene Deletion | 1 | 2011 | 235 | 0.020 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2001 | 201 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 1991 | 133 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2011 | 274 | 0.020 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1989 | 10 | 0.020 |
Why?
|
Rats, Long-Evans | 2 | 2001 | 203 | 0.020 |
Why?
|
Dehydroepiandrosterone | 1 | 1989 | 29 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 1985 | 529 | 0.020 |
Why?
|
Photochemistry | 1 | 1989 | 46 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 1989 | 41 | 0.020 |
Why?
|
Dimethyl Sulfoxide | 1 | 1989 | 30 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 50 | 0.020 |
Why?
|
Prazosin | 1 | 1989 | 10 | 0.020 |
Why?
|
DNA | 2 | 2002 | 597 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1989 | 63 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1989 | 117 | 0.020 |
Why?
|
Dibenzothiepins | 1 | 1988 | 1 | 0.020 |
Why?
|
Isoelectric Focusing | 1 | 1989 | 42 | 0.020 |
Why?
|
Obesity | 1 | 2016 | 1074 | 0.020 |
Why?
|
Dimercaprol | 1 | 1988 | 3 | 0.020 |
Why?
|
Aspartate Aminotransferases | 3 | 1985 | 87 | 0.020 |
Why?
|
Catalase | 1 | 1988 | 85 | 0.020 |
Why?
|
Eicosanoic Acids | 2 | 1985 | 3 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2008 | 181 | 0.020 |
Why?
|
Polymyxins | 1 | 1988 | 3 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2008 | 67 | 0.020 |
Why?
|
Autoradiography | 2 | 2003 | 94 | 0.020 |
Why?
|
Inositol Phosphates | 2 | 2001 | 28 | 0.020 |
Why?
|
Smoking | 1 | 2016 | 1449 | 0.020 |
Why?
|
Adenocarcinoma | 2 | 2005 | 475 | 0.020 |
Why?
|
South Carolina | 1 | 2015 | 2750 | 0.020 |
Why?
|
DNA Primers | 1 | 2008 | 302 | 0.020 |
Why?
|
Heptanoic Acids | 2 | 1994 | 28 | 0.020 |
Why?
|
Trypsin Inhibitors | 1 | 1987 | 15 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2007 | 12 | 0.020 |
Why?
|
Drug Resistance, Multiple | 1 | 2007 | 56 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1989 | 186 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2001 | 700 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 100 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 2 | 2006 | 331 | 0.020 |
Why?
|
Child, Preschool | 1 | 2014 | 3185 | 0.020 |
Why?
|
Interleukins | 1 | 2007 | 79 | 0.020 |
Why?
|
Mitochondria, Liver | 2 | 1983 | 148 | 0.020 |
Why?
|
Paclitaxel | 1 | 2007 | 140 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1987 | 117 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 710 | 0.020 |
Why?
|
Pulmonary Circulation | 2 | 1988 | 79 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2006 | 35 | 0.020 |
Why?
|
Cisplatin | 1 | 2007 | 192 | 0.020 |
Why?
|
Lipoproteins | 2 | 1985 | 161 | 0.020 |
Why?
|
Acrylates | 1 | 1986 | 17 | 0.020 |
Why?
|
Lipoxygenase | 1 | 1986 | 13 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 1989 | 232 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2010 | 595 | 0.020 |
Why?
|
Proteoglycans | 1 | 2006 | 103 | 0.020 |
Why?
|
History, 20th Century | 1 | 1987 | 248 | 0.020 |
Why?
|
Cell Fractionation | 1 | 1985 | 34 | 0.020 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2005 | 41 | 0.020 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2006 | 62 | 0.020 |
Why?
|
Insulin Infusion Systems | 1 | 1985 | 27 | 0.020 |
Why?
|
Prothrombin Time | 1 | 1985 | 24 | 0.020 |
Why?
|
Tubulin | 1 | 1985 | 60 | 0.020 |
Why?
|
Partial Thromboplastin Time | 1 | 1985 | 57 | 0.020 |
Why?
|
Cytoskeleton | 1 | 1985 | 84 | 0.020 |
Why?
|
Microtubules | 1 | 1985 | 104 | 0.020 |
Why?
|
Carbon Isotopes | 3 | 1970 | 54 | 0.020 |
Why?
|
Blood Substitutes | 1 | 1985 | 8 | 0.020 |
Why?
|
Chlortetracycline | 1 | 1984 | 1 | 0.020 |
Why?
|
Fibrinogen | 1 | 1985 | 87 | 0.020 |
Why?
|
Egtazic Acid | 1 | 1984 | 29 | 0.020 |
Why?
|
Cell Differentiation | 1 | 1989 | 1034 | 0.020 |
Why?
|
Electrolytes | 1 | 1985 | 47 | 0.020 |
Why?
|
Aminoquinolines | 1 | 1984 | 14 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 1987 | 59 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2006 | 156 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 332 | 0.020 |
Why?
|
Genotype | 1 | 2007 | 785 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 1986 | 167 | 0.020 |
Why?
|
Fluorescence | 1 | 1984 | 104 | 0.020 |
Why?
|
Adolescent | 3 | 2014 | 8903 | 0.020 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2004 | 33 | 0.020 |
Why?
|
Edetic Acid | 1 | 1984 | 29 | 0.020 |
Why?
|
Lipoproteins, IDL | 1 | 1983 | 8 | 0.020 |
Why?
|
Plasminogen Activators | 1 | 1983 | 19 | 0.020 |
Why?
|
Lipoproteins, VLDL | 1 | 1983 | 32 | 0.020 |
Why?
|
Densitometry | 1 | 2003 | 15 | 0.020 |
Why?
|
Piroxicam | 1 | 1983 | 1 | 0.020 |
Why?
|
Naproxen | 1 | 1983 | 3 | 0.020 |
Why?
|
Gallopamil | 1 | 1983 | 1 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 1983 | 49 | 0.010 |
Why?
|
Mesocricetus | 1 | 1983 | 32 | 0.010 |
Why?
|
Microsomes, Liver | 1 | 1983 | 44 | 0.010 |
Why?
|
Capillaries | 1 | 1984 | 105 | 0.010 |
Why?
|
Hydrogen Bonding | 1 | 2003 | 66 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 1983 | 112 | 0.010 |
Why?
|
beta-Thromboglobulin | 1 | 1983 | 7 | 0.010 |
Why?
|
Aminobenzoates | 1 | 1983 | 2 | 0.010 |
Why?
|
Blood Proteins | 1 | 2003 | 94 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2005 | 799 | 0.010 |
Why?
|
Glucocorticoids | 1 | 1985 | 222 | 0.010 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2003 | 2 | 0.010 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2003 | 4 | 0.010 |
Why?
|
Rolipram | 1 | 2003 | 9 | 0.010 |
Why?
|
Hydronephrosis | 1 | 1983 | 12 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 1983 | 161 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2003 | 28 | 0.010 |
Why?
|
Mice, Inbred NZB | 1 | 1982 | 37 | 0.010 |
Why?
|
Adenylyl Cyclases | 2 | 1998 | 94 | 0.010 |
Why?
|
Shock | 1 | 1983 | 28 | 0.010 |
Why?
|
Secretin | 1 | 1982 | 18 | 0.010 |
Why?
|
Renal Circulation | 1 | 1982 | 49 | 0.010 |
Why?
|
Sympathetic Nervous System | 2 | 1974 | 81 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 5708 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2003 | 202 | 0.010 |
Why?
|
Proteinuria | 1 | 1982 | 136 | 0.010 |
Why?
|
Strontium Radioisotopes | 1 | 1982 | 4 | 0.010 |
Why?
|
Vinblastine | 1 | 1982 | 40 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 1753 | 0.010 |
Why?
|
Inositol | 1 | 2001 | 11 | 0.010 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2001 | 9 | 0.010 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2001 | 9 | 0.010 |
Why?
|
Coronary Vasospasm | 1 | 2001 | 2 | 0.010 |
Why?
|
Antibodies, Antinuclear | 1 | 1982 | 171 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1983 | 179 | 0.010 |
Why?
|
Microspheres | 1 | 1982 | 59 | 0.010 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2001 | 29 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2001 | 60 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 78 | 0.010 |
Why?
|
Ovariectomy | 1 | 2001 | 49 | 0.010 |
Why?
|
Alcoholism | 1 | 1970 | 1109 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2001 | 76 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 1982 | 175 | 0.010 |
Why?
|
Cyclopentanes | 1 | 2001 | 15 | 0.010 |
Why?
|
Postmenopause | 1 | 2001 | 92 | 0.010 |
Why?
|
Escherichia coli | 1 | 2003 | 368 | 0.010 |
Why?
|
Drug Synergism | 1 | 1981 | 260 | 0.010 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 1981 | 9 | 0.010 |
Why?
|
Protein Kinases | 1 | 2001 | 122 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1985 | 848 | 0.010 |
Why?
|
Cricetulus | 1 | 2001 | 98 | 0.010 |
Why?
|
Protein Subunits | 1 | 2001 | 99 | 0.010 |
Why?
|
Coronary Disease | 1 | 1983 | 358 | 0.010 |
Why?
|
Depression, Chemical | 1 | 2000 | 29 | 0.010 |
Why?
|
Alkaline Phosphatase | 2 | 1977 | 71 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2005 | 624 | 0.010 |
Why?
|
Prostaglandins D | 1 | 1980 | 2 | 0.010 |
Why?
|
Electrophysiology | 1 | 1980 | 160 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 1982 | 296 | 0.010 |
Why?
|
Connective Tissue | 1 | 1980 | 61 | 0.010 |
Why?
|
Peroxisomes | 1 | 2000 | 48 | 0.010 |
Why?
|
alpha-Linolenic Acid | 1 | 1979 | 2 | 0.010 |
Why?
|
Linolenic Acids | 1 | 1979 | 3 | 0.010 |
Why?
|
Sciuridae | 1 | 1979 | 2 | 0.010 |
Why?
|
Linoleic Acids | 1 | 1979 | 12 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2001 | 307 | 0.010 |
Why?
|
Haplorhini | 1 | 1979 | 44 | 0.010 |
Why?
|
Papio | 1 | 1979 | 27 | 0.010 |
Why?
|
Platelet Activating Factor | 1 | 1979 | 34 | 0.010 |
Why?
|
Bucladesine | 1 | 1978 | 8 | 0.010 |
Why?
|
Dietary Fats | 1 | 1979 | 103 | 0.010 |
Why?
|
Phospholipases | 1 | 1978 | 12 | 0.010 |
Why?
|
Receptors, Prostaglandin E | 1 | 1998 | 8 | 0.010 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 1998 | 12 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1998 | 189 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1998 | 118 | 0.010 |
Why?
|
Aldosterone | 1 | 1977 | 51 | 0.010 |
Why?
|
Acetaminophen | 1 | 1977 | 111 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1998 | 742 | 0.010 |
Why?
|
Molsidomine | 1 | 1995 | 5 | 0.010 |
Why?
|
Lethal Dose 50 | 1 | 1995 | 13 | 0.010 |
Why?
|
omega-N-Methylarginine | 1 | 1995 | 14 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1995 | 23 | 0.010 |
Why?
|
Thymidine | 1 | 1995 | 32 | 0.010 |
Why?
|
Inbreeding | 1 | 1974 | 4 | 0.010 |
Why?
|
Denervation | 1 | 1974 | 23 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1995 | 107 | 0.010 |
Why?
|
Infant | 4 | 1989 | 2891 | 0.010 |
Why?
|
Salmonella Infections, Animal | 1 | 1994 | 5 | 0.010 |
Why?
|
Electrophoresis | 1 | 1995 | 69 | 0.010 |
Why?
|
Hormones | 1 | 1994 | 42 | 0.010 |
Why?
|
Hypercalcemia | 1 | 1974 | 34 | 0.010 |
Why?
|
Nephrectomy | 1 | 1974 | 103 | 0.010 |
Why?
|
Biological Assay | 1 | 1974 | 88 | 0.010 |
Why?
|
Cattle | 1 | 1995 | 475 | 0.010 |
Why?
|
Kidney Function Tests | 1 | 1994 | 114 | 0.010 |
Why?
|
Biphenyl Compounds | 1 | 1994 | 184 | 0.010 |
Why?
|
Sodium Fluoride | 1 | 1992 | 9 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1974 | 206 | 0.010 |
Why?
|
Tritium | 1 | 1992 | 101 | 0.010 |
Why?
|
Syndrome | 1 | 1991 | 255 | 0.010 |
Why?
|
Dihydroxyphenylalanine | 1 | 1970 | 13 | 0.010 |
Why?
|
Codeine | 1 | 1970 | 1 | 0.010 |
Why?
|
Dextropropoxyphene | 1 | 1970 | 1 | 0.010 |
Why?
|
Morphine Dependence | 1 | 1970 | 4 | 0.010 |
Why?
|
Pressoreceptors | 1 | 1970 | 15 | 0.010 |
Why?
|
Child | 2 | 1983 | 6400 | 0.010 |
Why?
|
Heart Septal Defects | 1 | 1989 | 27 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1968 | 52 | 0.010 |
Why?
|
Phospholipids | 1 | 1989 | 108 | 0.010 |
Why?
|
Free Radicals | 1 | 1988 | 65 | 0.010 |
Why?
|
Postoperative Period | 1 | 1989 | 238 | 0.010 |
Why?
|
Etidronic Acid | 2 | 1978 | 3 | 0.000 |
Why?
|
Esterases | 1 | 1987 | 9 | 0.000 |
Why?
|
Immune Sera | 1 | 1987 | 30 | 0.000 |
Why?
|
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 1 | 1987 | 1 | 0.000 |
Why?
|
Lung Compliance | 1 | 1987 | 10 | 0.000 |
Why?
|
Golgi Apparatus | 2 | 1977 | 75 | 0.000 |
Why?
|
Glutathione | 1 | 1988 | 343 | 0.000 |
Why?
|
Organ Size | 1 | 1987 | 242 | 0.000 |
Why?
|
Phospholipases A | 1 | 1986 | 41 | 0.000 |
Why?
|
Edema | 1 | 1986 | 66 | 0.000 |
Why?
|
Regional Blood Flow | 1 | 1986 | 168 | 0.000 |
Why?
|
Osmosis | 1 | 1985 | 38 | 0.000 |
Why?
|
Skin | 2 | 1980 | 451 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1985 | 47 | 0.000 |
Why?
|
Isotope Labeling | 1 | 1985 | 30 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1985 | 47 | 0.000 |
Why?
|
Amiloride | 1 | 1985 | 22 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1985 | 67 | 0.000 |
Why?
|
Diet, Sodium-Restricted | 1 | 1985 | 45 | 0.000 |
Why?
|
Cations, Divalent | 1 | 1984 | 27 | 0.000 |
Why?
|
Calmodulin | 1 | 1984 | 53 | 0.000 |
Why?
|
Oxygen Consumption | 1 | 1985 | 258 | 0.000 |
Why?
|
Random Allocation | 1 | 1985 | 442 | 0.000 |
Why?
|
Intestinal Mucosa | 1 | 1985 | 219 | 0.000 |
Why?
|
Heart | 1 | 1968 | 850 | 0.000 |
Why?
|
Hemoglobinometry | 1 | 1983 | 5 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1985 | 648 | 0.000 |
Why?
|
Body Height | 1 | 1983 | 67 | 0.000 |
Why?
|
Potassium | 1 | 1983 | 168 | 0.000 |
Why?
|
Posture | 1 | 1983 | 107 | 0.000 |
Why?
|
Diet | 1 | 1986 | 513 | 0.000 |
Why?
|
Creatinine | 1 | 1983 | 243 | 0.000 |
Why?
|
Ascitic Fluid | 1 | 1982 | 22 | 0.000 |
Why?
|
Colloids | 1 | 1982 | 43 | 0.000 |
Why?
|
Exercise Test | 1 | 1983 | 242 | 0.000 |
Why?
|
Carbon | 1 | 1982 | 122 | 0.000 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1981 | 189 | 0.000 |
Why?
|
Body Weight | 1 | 1983 | 554 | 0.000 |
Why?
|
Heart Rate | 1 | 1983 | 568 | 0.000 |
Why?
|
Prostaglandins E, Synthetic | 1 | 1980 | 5 | 0.000 |
Why?
|
Phytohemagglutinins | 1 | 1980 | 16 | 0.000 |
Why?
|
Myocardial Contraction | 1 | 1981 | 383 | 0.000 |
Why?
|
Electrocardiography | 1 | 1983 | 601 | 0.000 |
Why?
|
Alanine Transaminase | 1 | 1980 | 137 | 0.000 |
Why?
|
Factor VIII | 1 | 1979 | 27 | 0.000 |
Why?
|
Blood Coagulation Factors | 1 | 1979 | 44 | 0.000 |
Why?
|
Arteries | 1 | 1979 | 108 | 0.000 |
Why?
|
Secretory Rate | 1 | 1978 | 11 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1980 | 397 | 0.000 |
Why?
|
Half-Life | 1 | 1977 | 96 | 0.000 |
Why?
|
Cell Nucleolus | 1 | 1977 | 14 | 0.000 |
Why?
|
Lipid Metabolism | 1 | 1979 | 186 | 0.000 |
Why?
|
Intercellular Junctions | 1 | 1977 | 32 | 0.000 |
Why?
|
Prospective Studies | 1 | 1985 | 3702 | 0.000 |
Why?
|
Glycosaminoglycans | 1 | 1977 | 88 | 0.000 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 1977 | 131 | 0.000 |
Why?
|
Diabetic Retinopathy | 1 | 1976 | 109 | 0.000 |
Why?
|
Phosphorus | 1 | 1974 | 64 | 0.000 |
Why?
|
Diabetic Nephropathies | 1 | 1976 | 161 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1974 | 306 | 0.000 |
Why?
|
Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 1970 | 2 | 0.000 |
Why?
|
Tyramine | 1 | 1970 | 16 | 0.000 |
Why?
|
Carotid Sinus | 1 | 1970 | 5 | 0.000 |
Why?
|
Reflex | 1 | 1970 | 21 | 0.000 |
Why?
|